Functional constipation in Bangladeshi school aged children: A hidden misty at community

Md Benzamin1, Asm Bazlul Karim2, Md Rukunuzzaman2

  • 1Department of Paediatric Gastroenterology and Nutrition, Bangabandhu Shiekh Mujib Medical University, Dhaka 1000, Bangladesh. drmd.benzamin@yahoo.com.

Insights

Functional constipation affects 11% of Bangladeshi school children. Key risk factors include inadequate toilet access, family history, poor fluid intake, school toilet embarrassment, and excessive screen time, highlighting the need for targeted interventions.

Area of Science:

  • Pediatric Gastroenterology
  • Public Health
  • Epidemiology

Background:

  • Constipation is a prevalent pediatric issue, frequently leading to hospital visits.
  • Limited data exists on constipation prevalence in Bangladeshi school-aged children.
  • Varied presentations necessitate proper evaluation and management strategies.

Purpose of the Study:

  • To determine the prevalence of functional constipation among school-aged children in Bangladesh.
  • To identify significant risk factors associated with functional constipation in this population.

Main Methods:

  • A descriptive cross-sectional study was conducted in Dhaka division schools.
  • Rome IV criteria were used to diagnose functional constipation in 707 school-aged children (5-16 years).
  • Exclusion criteria included red flag signs, chronic diseases, or organic disease indicators.

Main Results:

  • 11% of children were diagnosed with functional constipation.
  • Risk factors identified include inadequate school toilet numbers (OR=2.49), embarrassment using school toilets (OR=3.55), family history (OR=3.98 for siblings, OR=2.57 for parents/grandparents), inadequate fluid intake (OR=1.97), and >2 hours of daily screen time (OR=2.14).
  • Symptoms like anorexia, nausea, abdominal pain, and hard stools were significantly higher in constipated children.

Conclusions:

  • Functional constipation is a significant issue among Bangladeshi school children.
  • Inadequate toilet facilities, family history, low fluid intake, school toilet avoidance, and high screen time are key modifiable risk factors.
  • Findings underscore the need for community-based interventions to address pediatric constipation.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
311
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
450
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
357
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
549
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
260
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
343